These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Systemic Intravenous Adoptive Transfer of Autologous Lymphokine-activated αβ T-Cells Improves Temozolomide-induced Lymphopenia in Patients with Glioma. Kanemura Y; Sumida M; Okita Y; Yoshioka E; Yamamoto A; Kanematsu D; Handa Y; Fukusumi H; Inazawa Y; Takada AI; Nonaka M; Nakajima S; Mori K; Goto S; Kamigaki T; Shofuda T; Moriuchi S; Yamasaki M Anticancer Res; 2017 Jul; 37(7):3921-3932. PubMed ID: 28668896 [TBL] [Abstract][Full Text] [Related]
13. [Multidisciplinary therapy using interferon and immunological evaluation for glioma patients: two-color analysis of T cell subsets]. Numa Y; Kawamoto K; Matsumura H No Shinkei Geka; 1991 Feb; 19(2):121-8. PubMed ID: 1708857 [TBL] [Abstract][Full Text] [Related]
14. A phase I clinical study of a cocktail vaccine of Wilms' tumor 1 (WT1) HLA class I and II peptides for recurrent malignant glioma. Tsuboi A; Hashimoto N; Fujiki F; Morimoto S; Kagawa N; Nakajima H; Hosen N; Nishida S; Nakata J; Morita S; Sakamoto J; Oji Y; Oka Y; Sugiyama H Cancer Immunol Immunother; 2019 Feb; 68(2):331-340. PubMed ID: 30430205 [TBL] [Abstract][Full Text] [Related]
15. Autologous natural killer cell therapy for human recurrent malignant glioma. Ishikawa E; Tsuboi K; Saijo K; Harada H; Takano S; Nose T; Ohno T Anticancer Res; 2004; 24(3b):1861-71. PubMed ID: 15274367 [TBL] [Abstract][Full Text] [Related]
16. Phase I trial of temozolomide using an extended continuous oral schedule. Brock CS; Newlands ES; Wedge SR; Bower M; Evans H; Colquhoun I; Roddie M; Glaser M; Brampton MH; Rustin GJ Cancer Res; 1998 Oct; 58(19):4363-7. PubMed ID: 9766665 [TBL] [Abstract][Full Text] [Related]
17. Whole-brain radiation therapy plus concomitant temozolomide for the treatment of brain metastases from non-small-cell lung cancer: a randomized, open-label phase II study. Chua D; Krzakowski M; Chouaid C; Pallotta MG; Martinez JI; Gottfried M; Curran W; Throuvalas N Clin Lung Cancer; 2010 May; 11(3):176-81. PubMed ID: 20439193 [TBL] [Abstract][Full Text] [Related]
18. Identification and characterization of a WT1 (Wilms Tumor Gene) protein-derived HLA-DRB1*0405-restricted 16-mer helper peptide that promotes the induction and activation of WT1-specific cytotoxic T lymphocytes. Fujiki F; Oka Y; Tsuboi A; Kawakami M; Kawakatsu M; Nakajima H; Elisseeva OA; Harada Y; Ito K; Li Z; Tatsumi N; Sakaguchi N; Fujioka T; Masuda T; Yasukawa M; Udaka K; Kawase I; Oji Y; Sugiyama H J Immunother; 2007 Apr; 30(3):282-93. PubMed ID: 17414319 [TBL] [Abstract][Full Text] [Related]
19. The impact of thrombocytopenia from temozolomide and radiation in newly diagnosed adults with high-grade gliomas. Gerber DE; Grossman SA; Zeltzman M; Parisi MA; Kleinberg L Neuro Oncol; 2007 Jan; 9(1):47-52. PubMed ID: 17108062 [TBL] [Abstract][Full Text] [Related]
20. Peptide epitopes from the Wilms' tumor 1 oncoprotein stimulate CD4+ and CD8+ T cells that recognize and kill human malignant mesothelioma tumor cells. May RJ; Dao T; Pinilla-Ibarz J; Korontsvit T; Zakhaleva V; Zhang RH; Maslak P; Scheinberg DA Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4547-55. PubMed ID: 17671141 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]